thiazolidines has been researched along with Lung Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelgawad, MA; Ahmed, S; Aziz, NAAM; Dawood, AF; El-Adl, K; El-Hddad, SSA; Ghoneim, MM; Hanafy, NS; Mohamady, S | 1 |
| Ahmad, A; Alam, MA; Alam, O; Haider, MR; Husain, A; Iqbal, MA; Khan, SA | 1 |
| Li, Q; Luan, Y; Wang, N; Zhang, J; Zhou, Y | 1 |
| Cross, DAE; Floc'h, N; Martin, MJ; Ménard, L | 1 |
| Cha, PH; Cho, J; Cho, YH; Choi, KY; Han, G; Kim, T; Lee, HY; Lee, J; Lee, SK; Min, DS; Park, J; Shin, WJ; Yang, JS | 1 |
| Abayasiriwardana, KS; Birnie, KA; Laurent, GJ; McAnulty, RJ; Mutsaers, SE; Prêle, CM; Robinson, BW; Wood, MK | 1 |
| Jiang, C; Li, F; Li, X; Liu, Y; Su, G; Wu, L; Yan, B; Zhai, S; Zhang, B; Zhang, C; Zhang, Q; Zhang, S; Zhou, H | 1 |
| Chen, Y; Li, J; Li, Y; Liu, M; Luo, J; Qin, L; Wang, P; Wu, J; Yang, F; Yi, Z; Yu, L; Zhou, W | 1 |
| Chiu, SJ; Hwang, JJ; Keng, PC; Lee, YJ; Sheu, TJ; Tsai, CH | 1 |
| Ji, H; Lai, Y; Li, Y; Sun, Y; Ye, X; Zhang, Y; Zhou, W | 1 |
| Gong, P; Lv, Y; Wang, S; Zhang, G; Zhang, N; Zhao, Y | 1 |
| Debeir, O; Decaestecker, C; Hayot, C; Kiss, R; Van Damme, M; Van Ham, P | 1 |
| Davis, JJ; Dong, F; Fang, B; Guo, W; Sasaki, J; Teraishi, F; Wu, S; Zhang, L | 1 |
| Davis, J; Dong, F; Fang, B; Guo, W; Kaluarachchi, K; Pang, J; Teraishi, F; Wu, S; Yan, B; Zhang, L | 1 |
| Kamataki, T | 1 |
| Sappino, AP; Smith, IE | 1 |
| Coppey, J; Magdelenat, H; Rigaud, O | 1 |
| Alberto, P | 1 |
| Barnabè, R; Berni, F; Clini, V; Pirrelli, M; Pisani Ceretti, A; Robuschi, M; Rossi, M; Sestini, P; Tana, F; Vaghi, A | 1 |
| DeGraff, W; Friedman, N; Mitchell, JB; Russo, A | 1 |
1 review(s) available for thiazolidines and Lung Neoplasms
| Article | Year |
|---|---|
[How I was enticed into molecular toxicology].
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Gene Deletion; Humans; Lung Neoplasms; Mixed Function Oxygenases; Molecular Biology; Nitrosamines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk; Smoking; Thiazolidines; Toxicology | 2006 |
1 trial(s) available for thiazolidines and Lung Neoplasms
| Article | Year |
|---|---|
The efficacy and safety of moguisteine in comparison with codeine phosphate in patients with chronic cough.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitussive Agents; Chronic Disease; Circadian Rhythm; Codeine; Cough; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis; Safety; Thiazoles; Thiazolidines | 1995 |
18 other study(ies) available for thiazolidines and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and docking of novel thiazolidine-2,4-dione multitarget scaffold as new approach for cancer treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Lung Neoplasms; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Structure-Activity Relationship; Thiazolidines; Vascular Endothelial Growth Factor Receptor-2 | 2023 |
Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Design; Female; Humans; Imidazoles; Lung Neoplasms; Male; MCF-7 Cells; Molecular Docking Simulation; Prostatic Neoplasms; Pyridines; Rats; Rats, Wistar; Thiazolidines; Toxicity Tests | 2020 |
A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Chlorophyllides; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Nanoparticles; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Rhodanine; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clathrin; Drug Resistance, Neoplasm; Endocytosis; ErbB Receptors; Humans; Lung Neoplasms; Lysosomes; Mutation; Protein Kinase Inhibitors; Proteolysis; Signal Transduction; Sulfonamides; Thiazolidines | 2018 |
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer.
Topics: Animals; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins p21(ras); ras Proteins; Thiazolidines | 2019 |
Inhibition of collagen production delays malignant mesothelioma tumor growth in a murine model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Collagen; Disease Models, Animal; Extracellular Matrix; Female; Humans; Inflammation; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred CBA; Pleural Neoplasms; Thiazolidines; Transforming Growth Factor beta | 2019 |
Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Molecular Targeted Therapy; Oligonucleotide Array Sequence Analysis; Signal Transduction; Structure-Activity Relationship; Thiazolidines; Time Factors; Tubulin Modulators; Xenograft Model Antitumor Assays | 2014 |
Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Design; Female; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Structure-Activity Relationship; Thiazolidines; Xenograft Model Antitumor Assays | 2014 |
Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton.
Topics: Actins; Adenocarcinoma; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytochalasin D; Cytoskeleton; DNA, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Osteosarcoma; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm; Thiazolidines; Ubiquitin | 2009 |
Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidines | 2010 |
Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Fibroblasts; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Lung Neoplasms; Pyrroles; Sunitinib; Thiazolidines | 2011 |
Characterization of the activities of actin-affecting drugs on tumor cell migration.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cytochalasin D; Cytoskeleton; Depsipeptides; Humans; Inhibitory Concentration 50; Lung Neoplasms; Neoplasm Invasiveness; Statistics, Nonparametric; Thiazoles; Thiazolidines | 2006 |
JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells.
Topics: Aniline Compounds; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Colonic Neoplasms; Enzyme Activation; Humans; Lung Neoplasms; Microtubules; Mitogen-Activated Protein Kinase 8; Mitosis; Spindle Apparatus; Thiazoles; Thiazolidines | 2005 |
Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Paclitaxel; Structure-Activity Relationship; Thiazolidines; Vinblastine; Vinorelbine | 2006 |
Thioproline in squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Psychoses, Substance-Induced; Thiazoles; Thiazolidines | 1980 |
Lack of reverse transformation after treatment of A 549 human alveolar carcinoma cells with thioproline.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Cell Division; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Phenotype; Thiazoles; Thiazolidines | 1983 |
Thioproline (Norgamem): a useless drug in the treatment of squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Lung Neoplasms; Thiazoles; Thiazolidines | 1981 |
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
Topics: Antineoplastic Agents; Bleomycin; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cisplatin; Glutathione; Humans; Lung; Lung Neoplasms; Melphalan; Methionine Sulfoximine; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Zinostatin | 1986 |